Mechanical valves offer superior long-term survival for aortic valve replacement patients aged 60, study finds
"The decision between a bioprosthetic and a mechanical valve is one of the most consequential for patients requiring aortic ...
Medscape17d
Better 5-Year Valve Performance With TAVI Than Surgery
CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a lower 5-year incidence of bioprosthetic valve dysfunction than surgery. Valve dysfunction was also ...
TCTMD27d
SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years
but with less risk of bioprosthetic valve dysfunction, in patients with small annuli and symptomatic severe aortic stenosis. Presenting the data here at CRT 2025, SMART lead Investigator Howard ...
Nature5y
Xenograft aortic bioprostheses are more durable than homografts
Increasing numbers of patients require aortic valve surgery ... either a homograft or the pretreated stentless xenograft bioprosthesis. Survival of patients after 8 years was about 80% for ...
Hospital Healthcare Europe10d
Mechanical aortic heart valves favoured for 50-70 age group, study suggests
Mechanical heart valves have improved long-term survival benefit over biological valves for patients aged 50-70 years, new ...
Hosted on MSN2mon
60 or Younger? A 'Wake Up Call' for Mechanical Aortic Valve Replacement
aHR 1.12 favoring bioprosthetic valves (95% CI 0.97-1.29) These findings were consistent in sensitivity analyses excluding pure aortic insufficiency, intermediate- or high-risk patients ...
Morningstar28d
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
In patients with aortic stenosis and a small aortic ... and continued superior valve performance as measured by bioprosthetic valve dysfunction (BVD) at two years for Evolut™ TAVR compared ...